Navigation Links
Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
Date:8/1/2008

LITTLE FALLS, N.J., Aug. 1 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced management changes at its Crosstex International, Inc. subsidiary, effective today. As planned, Richard Allen Orofino, President and a former owner of Crosstex, retired effective today after over 50 years with Crosstex, including 3 years following Cantel's acquisition of the company. Gary Steinberg and Mitchell Steinberg, also former owners of Crosstex who have served as Executive Vice-Presidents of Crosstex, have been promoted and will now lead the company. Gary Steinberg has been appointed Chief Executive Officer of Crosstex with full day-to-day responsibilities. Mitchell Steinberg has been appointed President and will focus primarily on the sales and marketing efforts. Mr. Orofino has agreed to serve in a consulting capacity following his retirement.

Andrew A. Krakauer, President of Cantel, said, "Richard has been a great leader for many years at Crosstex, and I would like to particularly thank him for his efforts over the last 3 years as Crosstex was integrated into the Cantel family of companies. His counsel and experience were key factors in the great success we have had with this acquisition. I have great confidence in Gary's and Mitchell's ability to continue to lead Crosstex. They have been partners with Richard for many years and greatly responsible for making Crosstex the leading healthcare disposables company that it is today."

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.

Contact: Andrew A. Krakauer Richard E. Moyer

President Cameron Associates, Inc.

Cantel Medical Corp. richard@cameronassoc.com

Phone: (973) 890-7220 Phone: (212) 554-5466


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
2. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
3. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
4. BioMS Medical to present at BMO Healthcare Conference
5. DeviceSpace(TM) to Host Medical Device and Diagnostics Career Fair in Minneapolis
6. Inverness Medical Innovations Announces Second Quarter 2008 Results
7. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
8. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
9. Arcadia Radiology Medical Group Chooses AMICAS
10. VNUS Medical Technologies to Present at BMO Capital Markets 2008 Focus on Healthcare Conference
11. China Medical Technologies Adjusts Conversion Rate of Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):